Tibial Cortex Transverse Transport Facilitates Severe Diabetic Foot Wound Healing via HIF-1α-Induced Angiogenesis
Journal of Inflammation Research · 2024-05 · Volume 17 · 2681-2696
DOI: 10.2147/jir.s456590 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Inflammation Research, 2024-05. Verfasst von Jie Liu und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Bone and Joint Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, People's Republic of China. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Themen: Wundversorgung, Diabetisches Fußsyndrom
Abstract (Originalsprache)
Purpose
Management of severe diabetic foot ulcers (DFUs) remains challenging. Tibial cortex transverse transport (TTT) facilitates healing and limb salvage in patients with recalcitrant DFUs. However, the underlying mechanism is largely unknown, necessitating the establishment of an animal model and mechanism exploration.
Methods
Severe DFUs were induced in rats, then assigned to TTT, sham, or control groups (n=16/group). The TTT group underwent a tibial corticotomy, with 6 days each of medial and lateral transport; the sham group had a corticotomy without transport. Ulcer healing was assessed through Laser Doppler, CT angiography, histology, and immunohistochemistry. Serum HIF-1α, PDGF-BB, SDF-1, and VEGF levels were measured by ELISA.
Results
The TTT group showed lower percentages of wound area, higher dermis thickness (all p < 0.001 expect for p = 0.001 for TTT vs Sham at day 6) and percentage of collagen content (all p < 0.001) than the other two groups. The TTT group had higher perfusion and vessel volume in the hindlimb (all p < 0.001). The number of CD31+ cells (all p < 0.001) and VEGFR2+ cells (at day 6, TTT vs Control, p = 0.001, TTT vs Sham, p = 0.006; at day 12, TTT vs Control, p = 0.003, TTT vs Sham, p = 0.01) were higher in the TTT group. The activity of HIF-1α, PDGF-BB, and SDF-1 was increased in the TTT group (all p < 0.001 except for SDF-1 at day 12, TTT vs Sham, p = 0.005). The TTT group had higher levels of HIF-1α, PDGF-BB, SDF-1, and VEGF in serum than the other groups (all p < 0.001).
Conclusion
TTT enhanced neovascularization and perfusion at the hindlimb and accelerated healing of the severe DFUs. The underlying mechanism is related to HIF-1α-induced angiogenesis.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Bone and Joint Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, People's Republic of China.
- Yulin Campus of Guangxi Medical University, Yulin, Guangxi, People's Republic of China.
- Research Center for Computer-Aided Drug Discovery, Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen, People's Republic of China.
- Department of Orthopaedics and Traumatology, The University of Hong Kong, Pokfulam, Hong Kong.
ORCID-Profile: William W Lu
Zitieren
APA
Liu, J., Huang, X., Su, H., Yu, J., Nie, X., Liu, K., Qin, W., Zhao, Y., Su, Y., Kuang, X., Chen, D., Lu, W. W., Chen, Y., & Hua, Q. (2024). Tibial Cortex Transverse Transport Facilitates Severe Diabetic Foot Wound Healing via HIF-1α-Induced Angiogenesis. Journal of Inflammation Research, Volume 17, 2681-2696. https://doi.org/10.2147/jir.s456590
Vancouver
Liu J, Huang X, Su H, Yu J, Nie X, Liu K, et al. Tibial Cortex Transverse Transport Facilitates Severe Diabetic Foot Wound Healing via HIF-1α-Induced Angiogenesis. Journal of Inflammation Research. 2024;Volume 17:2681-2696. doi:10.2147/jir.s456590
BibTeX
@article{Liu2024,
author = {Liu, Jie and Huang, Xiajie and Su, Hongjie and Yu, Jie and Nie, Xinyu and Liu, Kaibing and Qin, Wencong and Zhao, Yongxin and Su, Yongfeng and Kuang, Xiaocong and Chen, Di and Lu, William W and Chen, Yan and Hua, Qikai},
title = {Tibial Cortex Transverse Transport Facilitates Severe Diabetic Foot Wound Healing via HIF-1α-Induced Angiogenesis},
journal = {Journal of Inflammation Research},
year = {2024},
volume = {Volume 17},
pages = {2681--2696},
doi = {10.2147/jir.s456590}
}
EUVIMED